Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 November 2023 | Story Anthony Mthembu | Photo SUPPLIED
Katherine Swartland
Katherine Swartland, a representative from Allan Gray addressing the delegation at the Allan Gray Achievement Awards, hosted on the UFS’s Bloemfontein Campus.

The Faculty of Economics and Management Sciences (EMS) at the University of the Free State (UFS), in collaboration with Allan Gray, proudly hosted the annual Allan Gray Achievement Awards on 11 October 2023. This special event, held at the Awela Restaurant on the UFS’s Bloemfontein campus, was designed to celebrate the academic achievements of top-performing students within the faculty, recognising their excellence based on their year of study. 

The award ceremony was attended by distinguished members of the EMS Faculty, the Commercio Students Association, and a delegation from Allan Gray, including Katherine Swartland, Managing Business Analyst, Yonela Makalima, Business Analyst, and Steven Motloung, Manager. The evening's guest speaker was Liz Letsoalo, a renowned entrepreneur and TEDx speaker. Notably, this ceremony marked a significant return to in-person events since the outbreak of the COVID-19 pandemic, and Katherine Swartland, who served as the programme director, described this resurgence as truly exciting. 

The award winners

The Allan Gray Achievement Awards highlighted outstanding students from various year levels. In the second-year category, Modisaotsile Seekoei received a prestigious award of R5 000 along with a Thule backpack, while Melissa Mlotshwa was granted a prize of R3 000. Among the third-year students, Anthea Ralane was recognised with an award of R8 000 and a Thule backpack, and Modiehi Mpakathe was the recipient of a R5 000 prize. In the fourth-year category, Kelebogile Motlhanke earned a remarkable R12 000 reward and a Thule backpack, and Rykers Lues was presented with a prize worth R8 000. 

Although not all students attending the ceremony received awards, Prof Brownhilder Neneh, the Vice Dean for Research Engagement and Internationalisation, aptly reminded the audience, ’It is important to recognise that each of you here is already a winner, as your presence signifies that you are among the top achievers in your field. You have demonstrated that with passion, perseverance, and a commitment to your goals, there are no limits to what you can accomplish.’’ 

A longstanding relationship

The Allan Gray Achievement Awards holds deep roots in a special relationship between the UFS and Allan Gray. Swartland noted that this initiative was founded by Faizil Jakoet, an executive at Allan Gray, and the awards ceremony, in part, celebrates the continued partnership between the UFS and Allan Gray. This enduring relationship has thrived for over a decade, despite changes in leadership, creating opportunities for meaningful engagement between Allan Gray and UFS students. Swartland further emphasised the importance of this bond, saying, ‘’Another special relationship is formed every time we visit the UFS, between us and you, a lot of exceptional students.” 

As the event approached its conclusion, the audience had the privilege of hearing from guest speaker Liz Letsoalo, Founder of Masodi Organics, a prominent beauty and wellness brand. Letsoalo’s address centered on the ‘practicality of creating’, encouraging students to view themselves as creators, allowing them to pivot and adapt as their aspirations evolve. She urged students to stay dedicated to their dreams, emphasising that taking necessary actions and persevering is essential to turning their dreams into reality.

The Allan Gray Achievement Awards signify the remarkable achievements and potential of the UFS EMS Faculty students. This event not only celebrates academic excellence, but also reinforces the enduring partnership between the University of the Free State and Allan Gray, paving the way for further opportunities and engagement.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept